Capricor Therapeutics Statistics
Total Valuation
CAPR has a market cap or net worth of $1.15 billion. The enterprise value is $882.25 million.
| Market Cap | 1.15B |
| Enterprise Value | 882.25M |
Important Dates
The next estimated earnings date is Monday, August 10, 2026, after market close.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CAPR has 57.91 million shares outstanding. The number of shares has increased by 27.43% in one year.
| Current Share Class | 57.91M |
| Shares Outstanding | 57.91M |
| Shares Change (YoY) | +27.43% |
| Shares Change (QoQ) | +17.57% |
| Owned by Insiders (%) | 1.04% |
| Owned by Institutions (%) | 52.00% |
| Float | 48.55M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 8.79 |
| PB Ratio | 4.09 |
| P/TBV Ratio | 4.11 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.42, with a Debt / Equity ratio of 0.05.
| Current Ratio | 8.42 |
| Quick Ratio | 8.28 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -39.38 |
Financial Efficiency
Return on equity (ROE) is -56.40% and return on invested capital (ROIC) is -35.49%.
| Return on Equity (ROE) | -56.40% |
| Return on Assets (ROA) | -31.23% |
| Return on Invested Capital (ROIC) | -35.49% |
| Return on Capital Employed (ROCE) | -40.98% |
| Weighted Average Cost of Capital (WACC) | 6.68% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$496,077 |
| Employee Count | 231 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CAPR has paid $1,600 in taxes.
| Income Tax | 1,600 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +187.65% in the last 52 weeks. The beta is 0.42, so CAPR's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | +187.65% |
| 50-Day Moving Average | 26.16 |
| 200-Day Moving Average | 23.15 |
| Relative Strength Index (RSI) | 29.82 |
| Average Volume (20 Days) | 1,727,714 |
Short Selling Information
The latest short interest is 14.74 million, so 25.45% of the outstanding shares have been sold short.
| Short Interest | 14.74M |
| Short Previous Month | 11.70M |
| Short % of Shares Out | 25.45% |
| Short % of Float | 30.36% |
| Short Ratio (days to cover) | 10.41 |
Income Statement
| Revenue | n/a |
| Gross Profit | -92.92M |
| Operating Income | -119.93M |
| Pretax Income | -114.59M |
| Net Income | -114.59M |
| EBITDA | -117.91M |
| EBIT | -119.93M |
| Earnings Per Share (EPS) | -$2.32 |
Balance Sheet
The company has $278.61 million in cash and $14.78 million in debt, with a net cash position of $263.83 million or $4.56 per share.
| Cash & Cash Equivalents | 278.61M |
| Total Debt | 14.78M |
| Net Cash | 263.83M |
| Net Cash Per Share | $4.56 |
| Equity (Book Value) | 278.70M |
| Book Value Per Share | 4.83 |
| Working Capital | 249.45M |
Cash Flow
In the last 12 months, operating cash flow was -$92.63 million and capital expenditures -$21.33 million, giving a free cash flow of -$113.96 million.
| Operating Cash Flow | -92.63M |
| Capital Expenditures | -21.33M |
| Depreciation & Amortization | 2.02M |
| Net Borrowing | n/a |
| Free Cash Flow | -113.96M |
| FCF Per Share | -$1.97 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CAPR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -27.43% |
| Shareholder Yield | -27.43% |
| Earnings Yield | -10.00% |
| FCF Yield | -9.94% |
Analyst Forecast
The average price target for CAPR is $53.60, which is 170.84% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $53.60 |
| Price Target Difference | 170.84% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 5, 2019. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jun 5, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |